Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 10, 2016, Pages 2065-2075

  Sarkar, Abhijit ^a   Ghosh, Shatadal ^a   Chowdhury, Sayantani ^a   Pandey, Bhawna ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Apoptosis; Biodistribution; Breast cancer; Ex ovo; Folic acid; Nanoparticle

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; MESOPOROUS SILICA NANOPARTICLE; PROTEIN BAX; PROTEIN KINASE B; QUERCETIN; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CELL CYCLE ARREST; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMBRYO; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR REGRESSION; WOUND HEALING; ANIMAL; BREAST NEOPLASMS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; FEMALE; MCF-7 CELL LINE; MOUSE; PATHOLOGY; POROSITY; SYNTHESIS;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; FOLIC ACID; HUMANS; MCF-7 CELLS; MICE; NANOPARTICLES; POROSITY; QUERCETIN; SILICON DIOXIDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84978863404     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.07.001     Document Type: Article

References (52)

1. [1] Kelly, G.S., Quercetin. Monograph. Altern. Med. Rev. J. Clin. Ther. 16 (2011), 172–194.
2. [2] Hossain, P., Kawar, B., El Nahas, M., Obesity and diabetes in the developing world — a growing challenge. N. Engl. J. Med. 356 (2007), 213–215.
3. [3] Hwang, J.-T., Kwon, D.Y., Yoon, S.H., AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotechnol. 26 (2009), 17–22.
4. [4] Bors, W., Heller, W., Michel, C., Saran, M., Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 186 (1990), 343–355.
5. [5] Prior, R.L., Fruits and vegetables in the prevention of cellular oxidative damage. Am. J. Clin. Nutr. 78 (2003), 570 s–578 s.
6. [6] Tabassum, H., Parvez, S., Rehman, H., Banerjee, B.D., Raisuddin, S., Catechin as an antioxidant in liver mitochondrial toxicity: inhibition of tamoxifen-induced protein oxidation and lipid peroxidation. J. Biochem. Mol. Toxicol. 21 (2007), 110–117.
7. [7] Chou, C.C., Yang, J.S., Lu, H.F., Ip, S.W., Lo, C., Wu, C.C., Lin, J.P., Tang, N.Y., Chung, J.G., Chou, M.J., Teng, Y.H., Chen, D.R., Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch. Pharm. Res. 33 (2010), 1181–1191.
8. [8] Lee, D.H., Szczepanski, M., Lee, Y.J., Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem. Pharmacol. 75 (2008), 2345–2355.
9. [9] Yang, J.H., Hsia, T.C., Kuo, H.M., Chao, P.D., Chou, C.C., Wei, Y.H., Chung, J.G., Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab. Dispos. Biol. Fate Chem. 34 (2006), 296–304.
10. [10] Lee, T.J., Kim, O.H., Kim, Y.H., Lim, J.H., Kim, S., Park, J.W., Kwon, T.K., Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 240 (2006), 234–242.
11. [11] Choi, J.A., Kim, J.Y., Lee, J.Y., Kang, C.M., Kwon, H.J., Yoo, Y.D., Kim, T.W., Lee, Y.S., Lee, S.J., Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol. 19 (2001), 837–844.
12. [12] Ong, C.S., Tran, E., Nguyen, T.T., Ong, C.K., Lee, S.K., Lee, J.J., Ng, C.P., Leong, C., Huynh, H., Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol. Rep. 11 (2004), 727–733.
13. [13] Beniston, R.G., Campo, M.S., Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. Oncogene 22 (2003), 5504–5514.
14. [14] Lee, K.W., Bode, A.M., Dong, Z., Molecular targets of phytochemicals for cancer prevention. Nat. Rev. Cancer 11 (2011), 211–218.
15. [15] Jaganathan, H., Godin, B., Biocompatibility assessment of Si-based nano- and micro-particles. Adv. Drug Deliv. Rev. 64 (2012), 1800–1819.
16. [16] Sarkar, A., Das, J., Manna, P., Sil, P.C., Nano-copper induces oxidative stress and apoptosis in kidney via both extrinsic and intrinsic pathways. Toxicology 290 (2011), 208–217.
17. [17] Day, A.J., Bao, Y., Morgan, M.R., Williamson, G., Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med. 29 (2000), 1234–1243.
18. [18] Sharma, G., Park, J., Sharma, A.R., Jung, J.S., Kim, H., Chakraborty, C., Song, D.K., Lee, S.S., Nam, J.S., Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Pharm. Res. 32 (2015), 723–735.
19. [19] Tan, Q., Liu, W., Guo, C., Zhai, G., Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int. J. Nanomedicine 6 (2011), 1621–1630.
20. [20] Parker, N., Turk, M.J., Westrick, E., Lewis, J.D., Low, P.S., Leamon, C.P., Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338 (2005), 284–293.
21. [21] Garin-Chesa, P., Campbell, I., Saigo, P.E., Lewis, J.L. Jr., Old, L.J., Rettig, W.J., Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142 (1993), 557–567.
22. [22] Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983), 55–63.
23. [23] Gupta, V., Aseh, A., Ríos, C.N., Aggarwal, B.B., Mathur, A.B., Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy. Int. J. Nanomedicine 4 (2009), 115–122.
24. [24] Sinha, K., Sadhukhan, P., Saha, S., Pal, P.B., Sil, P.C., Morin protects gastric mucosa from nonsteroidal anti-inflammatory drug, indomethacin induced inflammatory damage and apoptosis by modulating NF-κB pathway. Biochim. Biophys. Acta Gen. Subj. 1850 (2015), 769–783.
25. [25] Riccardi, C., Nicoletti, I., Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 1 (2006), 1458–1461.
26. [26] Sarkar, A., Sil, P.C., Iron oxide nanoparticles mediated cytotoxicity via PI3K/AKT pathway: role of quercetin. Food Chem. Toxicol. 71 (2014), 106–115.
27. [27] Ahir, M., Bhattacharya, S., Karmakar, S., Mukhopadhyay, A., Mukherjee, S., Ghosh, S., Chattopadhyay, S., Patra, P., Adhikary, A., Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells. Biomaterials 76 (2016), 115–132.
28. [28] Wickman, G.R., Julian, L., Mardilovich, K., Schumacher, S., Munro, J., Rath, N., Zander, S.A., Mleczak, A., Sumpton, D., Morrice, N., Bienvenut, W.V., Olson, M.F., Blebs produced by actin-myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs. Cell Death Differ. 20 (2013), 1293–1305.
29. [29] Barrera, G., Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol., 2012, 2012, 137289.
30. [30] Zijlstra, A., Mellor, R., Panzarella, G., Aimes, R.T., Hooper, J.D., Marchenko, N.D., Quigley, J.P., A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res. 62 (2002), 7083–7092.
31. [31] de Barros, A.L., de Oliveira Ferraz, K.S., Dantas, T.C., Andrade, G.F., Cardoso, V.N., Sousa, E.M., Synthesis, characterization, and biodistribution studies of (99m)Tc-labeled SBA-16 mesoporous silica nanoparticles. Mater. Sci. Eng., C 56 (2015), 181–188.
32. [32] Nikolić, M., Giannakopoulos, K.P., Srdić, V.V., Synthesis and characterization of mesoporous silica core-shell particles. Process. Appl. Ceram. 4 (2010), 81–85.
33. [33] Sapino, S., Ugazio, E., Gastaldi, L., Miletto, I., Berlier, G., Zonari, D., Oliaro-Bosso, S., Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies. Eur. J. Pharm. Biopharm. 89 (2015), 116–125.
34. [34] Dai, W., Gao, Q., Qiu, J., Yuan, J., Wu, G., Shen, G., Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. Tumor Biol., 2015.
35. [35] Gallagher, S.M., Castorino, J.J., Wang, D., Philp, N.J., Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res. 67 (2007), 4182–4189.
36. [36] Matsui, J., Funahashi, Y., Uenaka, T., Watanabe, T., Tsuruoka, A., Asada, M., Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin. Cancer Res. 14 (2008), 5459–5465.
37. [37] Deryugina, E.I., Quigley, J.P., Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules. Methods Enzymol. 444 (2008), 21–41.
38. [38] Chambers, A.F., Shafir, R., Ling, V., A model system for studying metastasis using the embryonic chick. Cancer Res. 42 (1982), 4018–4025.
39. [39] Kobayashi, T., Koshida, K., Endo, Y., Imao, T., Uchibayashi, T., Sasaki, T., Namiki, M., A chick embryo model for metastatic human prostate cancer. Eur. Urol. 34 (1998), 154–160.
40. [40] Ossowski, L., Reich, E., Experimental model for quantitative study of metastasis. Cancer Res. 40 (1980), 2300–2309.
41. [41] MacDonald, I.C., Schmidt, E.E., Morris, V.L., Chambers, A.F., Groom, A.C., Intravital videomicroscopy of the chorioallantoic microcirculation: a model system for studying metastasis. Microvasc. Res. 44 (1992), 185–199.
42. [42] Wilczewska, A.Z., Niemirowicz, K., Markiewicz, K.H., Car, H., Nanoparticles as drug delivery systems. Pharmacol. Rep. 64 (2012), 1020–1037.
43. [43] Brannon-Peppas, L., Blanchette, J.O., Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 64 (2012), 206–212 Supplement.
44. [44] Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Russo, G.L., The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83 (2012), 6–15.
45. [45] Vidya Priyadarsini, R., Senthil Murugan, R., Maitreyi, S., Ramalingam, K., Karunagaran, D., Nagini, S., The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur. J. Pharmacol. 649 (2010), 84–91.
46. [46] Priego, S., Feddi, F., Ferrer, P., Mena, S., Benlloch, M., Ortega, A., Carretero, J., Obrador, E., Asensi, M., Estrela, J.M., Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Mol. Cancer Ther. 7 (2008), 3330–3342.
47. [47] Duraj, J., Zazrivcova, K., Bodo, J., Sulikova, M., Sedlak, J., Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma 52 (2005), 273–279.
48. [48] Kang, J.W., Kim, J.H., Song, K., Kim, S.H., Yoon, J.H., Kim, K.S., Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother. Res. 24:Suppl. 1 (2010), S77–S82.
49. [49] Xiang, T., Fang, Y., Wang, S.X., Quercetin suppresses HeLa cells by blocking PI3K/Akt pathway. J. Huazhong Univ. Sci. Technolog. Med. Sci. 34 (2014), 740–744 Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
50. [50] Zhuang, J., Hawkins, S.F., Glenn, M.A., Lin, K., Johnson, G.G., Carter, A., Cawley, J.C., Pettitt, A.R., Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition. Haematologica 95 (2010), 110–118.
51. [51] El Hasasna, H., Saleh, A., Samri, H.A., Athamneh, K., Attoub, S., Arafat, K., Benhalilou, N., Alyan, S., Viallet, J., Dhaheri, Y.A., Eid, A., Iratni, R., Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFkappaB and nitric oxide pathways. Sci. Report., 6, 2016, 21144.
52. [52] Sosinska, P., Mikula-Pietrasik, J., Kuczmarska, A., Ksiazek, K., Intraperitoneal invasiveness of ovarian cancer from the cellular and molecular perspective. Ginekol. Pol. 86 (2015), 782–786.